Symptomatic atherosclerotic vascular disease and graft survival in primary kidney transplant recipients – Observational analysis of the united network of organ sharing database
The aim of this study was to investigate whether symptomatic atherosclerotic vascular disease (SAVD) was associated with graft survival in primary kidney transplant recipients. Recipient atherosclerotic vascular disease is associated with increased mortality rates amongst renal transplant patients....
Gespeichert in:
Veröffentlicht in: | Transplant immunology 2022-12, Vol.75, p.101734-101734, Article 101734 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 101734 |
---|---|
container_issue | |
container_start_page | 101734 |
container_title | Transplant immunology |
container_volume | 75 |
creator | Otunla, Afolarin A. Shanmugarajah, Kumaran Salciccioli, Justin D. Marshall, Dominic C. Davies, Alun H. Madariaga, Maria Lucia Shalhoub, Joseph |
description | The aim of this study was to investigate whether symptomatic atherosclerotic vascular disease (SAVD) was associated with graft survival in primary kidney transplant recipients.
Recipient atherosclerotic vascular disease is associated with increased mortality rates amongst renal transplant patients. However, its relationship with graft survival has not been well studied.
This retrospective observational analysis was performed using data for adult kidney transplant recipients between 11/09/2000 and 28/02/2020 extracted from the UNOS national organ transplantation database. Patients were divided into two groups based on recipient history of symptomatic atherosclerotic disease (angina or peripheral vascular disease). Risk-adjusted outcomes were assessed by multivariate Cox regression analysis adjusting for both donor and recipient characteristics.
11,771 adult kidney transplant recipients from the UNOS database were eligible for analysis (1543 had a history of SAVD, 10,228 did not have a history of SAVD). After adjusting for confounders, positive SAVD status was associated with an adverse effect on graft survival at both 1 year (HR 1.35, p |
doi_str_mv | 10.1016/j.trim.2022.101734 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2732538286</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0966327422002088</els_id><sourcerecordid>2732538286</sourcerecordid><originalsourceid>FETCH-LOGICAL-c214t-603550b867e74878f7d0b60e0ee8d67f6ea2b46e2059a2d185e634e68bdfaa353</originalsourceid><addsrcrecordid>eNp9kT1u3DAQhYkgAbxxcgFXLNNoTVESqQXSBEb-AAMunNTEiBytudZSCodSsF3ukJvkSD5JKKxrN0NwMI-P8z3GrkqxLUWprg_bFP1xK4WUa0NX9Su2KVvdFk29k6_ZRuyUKiqp6wv2lugghJDNTm_Yv_vTcUrjEZK3HNIDxpHskOt6X4DsPEDkzhMCIYfg-D5CnzjNcfELDNwHPmVriCf-6F3AE08RAk0DhMQjWj95DIn405-__K4jjEu2GkNWQi4n8sTHnmdjPgef0PGA6fcYH9fuGPcQOD1A9GHPHSTo8i_esTc9DITvn89L9vPL5x8334rbu6_fbz7dFlaWdSqUqJpGdK3SqOtMotdOdEqgQGyd0r1CkF2tUIpmB9KVbYOqqlG1nesBqqa6ZB_O705x_DUjJXP0ZHHIm-E4k5G6kk3VylblUXketRkfRezNMxNTCrMGZA5mDcisAZlzQFn08SzCvMTiMRqymZVF5zO3ZNzoX5L_B7PnoFQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2732538286</pqid></control><display><type>article</type><title>Symptomatic atherosclerotic vascular disease and graft survival in primary kidney transplant recipients – Observational analysis of the united network of organ sharing database</title><source>Elsevier ScienceDirect Journals</source><creator>Otunla, Afolarin A. ; Shanmugarajah, Kumaran ; Salciccioli, Justin D. ; Marshall, Dominic C. ; Davies, Alun H. ; Madariaga, Maria Lucia ; Shalhoub, Joseph</creator><creatorcontrib>Otunla, Afolarin A. ; Shanmugarajah, Kumaran ; Salciccioli, Justin D. ; Marshall, Dominic C. ; Davies, Alun H. ; Madariaga, Maria Lucia ; Shalhoub, Joseph</creatorcontrib><description>The aim of this study was to investigate whether symptomatic atherosclerotic vascular disease (SAVD) was associated with graft survival in primary kidney transplant recipients.
Recipient atherosclerotic vascular disease is associated with increased mortality rates amongst renal transplant patients. However, its relationship with graft survival has not been well studied.
This retrospective observational analysis was performed using data for adult kidney transplant recipients between 11/09/2000 and 28/02/2020 extracted from the UNOS national organ transplantation database. Patients were divided into two groups based on recipient history of symptomatic atherosclerotic disease (angina or peripheral vascular disease). Risk-adjusted outcomes were assessed by multivariate Cox regression analysis adjusting for both donor and recipient characteristics.
11,771 adult kidney transplant recipients from the UNOS database were eligible for analysis (1543 had a history of SAVD, 10,228 did not have a history of SAVD). After adjusting for confounders, positive SAVD status was associated with an adverse effect on graft survival at both 1 year (HR 1.35, p < 0.001) and 10 years (HR 1.15, p < 0.001).
SAVD should be considered an independent risk factor for poor prognosis in patients undergoing kidney transplant.</description><identifier>ISSN: 0966-3274</identifier><identifier>EISSN: 1878-5492</identifier><identifier>DOI: 10.1016/j.trim.2022.101734</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Atherosclerosis ; Graft survival ; Kidney transplantation ; Prognostication ; Rejection</subject><ispartof>Transplant immunology, 2022-12, Vol.75, p.101734-101734, Article 101734</ispartof><rights>2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c214t-603550b867e74878f7d0b60e0ee8d67f6ea2b46e2059a2d185e634e68bdfaa353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0966327422002088$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids></links><search><creatorcontrib>Otunla, Afolarin A.</creatorcontrib><creatorcontrib>Shanmugarajah, Kumaran</creatorcontrib><creatorcontrib>Salciccioli, Justin D.</creatorcontrib><creatorcontrib>Marshall, Dominic C.</creatorcontrib><creatorcontrib>Davies, Alun H.</creatorcontrib><creatorcontrib>Madariaga, Maria Lucia</creatorcontrib><creatorcontrib>Shalhoub, Joseph</creatorcontrib><title>Symptomatic atherosclerotic vascular disease and graft survival in primary kidney transplant recipients – Observational analysis of the united network of organ sharing database</title><title>Transplant immunology</title><description>The aim of this study was to investigate whether symptomatic atherosclerotic vascular disease (SAVD) was associated with graft survival in primary kidney transplant recipients.
Recipient atherosclerotic vascular disease is associated with increased mortality rates amongst renal transplant patients. However, its relationship with graft survival has not been well studied.
This retrospective observational analysis was performed using data for adult kidney transplant recipients between 11/09/2000 and 28/02/2020 extracted from the UNOS national organ transplantation database. Patients were divided into two groups based on recipient history of symptomatic atherosclerotic disease (angina or peripheral vascular disease). Risk-adjusted outcomes were assessed by multivariate Cox regression analysis adjusting for both donor and recipient characteristics.
11,771 adult kidney transplant recipients from the UNOS database were eligible for analysis (1543 had a history of SAVD, 10,228 did not have a history of SAVD). After adjusting for confounders, positive SAVD status was associated with an adverse effect on graft survival at both 1 year (HR 1.35, p < 0.001) and 10 years (HR 1.15, p < 0.001).
SAVD should be considered an independent risk factor for poor prognosis in patients undergoing kidney transplant.</description><subject>Atherosclerosis</subject><subject>Graft survival</subject><subject>Kidney transplantation</subject><subject>Prognostication</subject><subject>Rejection</subject><issn>0966-3274</issn><issn>1878-5492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kT1u3DAQhYkgAbxxcgFXLNNoTVESqQXSBEb-AAMunNTEiBytudZSCodSsF3ukJvkSD5JKKxrN0NwMI-P8z3GrkqxLUWprg_bFP1xK4WUa0NX9Su2KVvdFk29k6_ZRuyUKiqp6wv2lugghJDNTm_Yv_vTcUrjEZK3HNIDxpHskOt6X4DsPEDkzhMCIYfg-D5CnzjNcfELDNwHPmVriCf-6F3AE08RAk0DhMQjWj95DIn405-__K4jjEu2GkNWQi4n8sTHnmdjPgef0PGA6fcYH9fuGPcQOD1A9GHPHSTo8i_esTc9DITvn89L9vPL5x8334rbu6_fbz7dFlaWdSqUqJpGdK3SqOtMotdOdEqgQGyd0r1CkF2tUIpmB9KVbYOqqlG1nesBqqa6ZB_O705x_DUjJXP0ZHHIm-E4k5G6kk3VylblUXketRkfRezNMxNTCrMGZA5mDcisAZlzQFn08SzCvMTiMRqymZVF5zO3ZNzoX5L_B7PnoFQ</recordid><startdate>202212</startdate><enddate>202212</enddate><creator>Otunla, Afolarin A.</creator><creator>Shanmugarajah, Kumaran</creator><creator>Salciccioli, Justin D.</creator><creator>Marshall, Dominic C.</creator><creator>Davies, Alun H.</creator><creator>Madariaga, Maria Lucia</creator><creator>Shalhoub, Joseph</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202212</creationdate><title>Symptomatic atherosclerotic vascular disease and graft survival in primary kidney transplant recipients – Observational analysis of the united network of organ sharing database</title><author>Otunla, Afolarin A. ; Shanmugarajah, Kumaran ; Salciccioli, Justin D. ; Marshall, Dominic C. ; Davies, Alun H. ; Madariaga, Maria Lucia ; Shalhoub, Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c214t-603550b867e74878f7d0b60e0ee8d67f6ea2b46e2059a2d185e634e68bdfaa353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Atherosclerosis</topic><topic>Graft survival</topic><topic>Kidney transplantation</topic><topic>Prognostication</topic><topic>Rejection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Otunla, Afolarin A.</creatorcontrib><creatorcontrib>Shanmugarajah, Kumaran</creatorcontrib><creatorcontrib>Salciccioli, Justin D.</creatorcontrib><creatorcontrib>Marshall, Dominic C.</creatorcontrib><creatorcontrib>Davies, Alun H.</creatorcontrib><creatorcontrib>Madariaga, Maria Lucia</creatorcontrib><creatorcontrib>Shalhoub, Joseph</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplant immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Otunla, Afolarin A.</au><au>Shanmugarajah, Kumaran</au><au>Salciccioli, Justin D.</au><au>Marshall, Dominic C.</au><au>Davies, Alun H.</au><au>Madariaga, Maria Lucia</au><au>Shalhoub, Joseph</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Symptomatic atherosclerotic vascular disease and graft survival in primary kidney transplant recipients – Observational analysis of the united network of organ sharing database</atitle><jtitle>Transplant immunology</jtitle><date>2022-12</date><risdate>2022</risdate><volume>75</volume><spage>101734</spage><epage>101734</epage><pages>101734-101734</pages><artnum>101734</artnum><issn>0966-3274</issn><eissn>1878-5492</eissn><abstract>The aim of this study was to investigate whether symptomatic atherosclerotic vascular disease (SAVD) was associated with graft survival in primary kidney transplant recipients.
Recipient atherosclerotic vascular disease is associated with increased mortality rates amongst renal transplant patients. However, its relationship with graft survival has not been well studied.
This retrospective observational analysis was performed using data for adult kidney transplant recipients between 11/09/2000 and 28/02/2020 extracted from the UNOS national organ transplantation database. Patients were divided into two groups based on recipient history of symptomatic atherosclerotic disease (angina or peripheral vascular disease). Risk-adjusted outcomes were assessed by multivariate Cox regression analysis adjusting for both donor and recipient characteristics.
11,771 adult kidney transplant recipients from the UNOS database were eligible for analysis (1543 had a history of SAVD, 10,228 did not have a history of SAVD). After adjusting for confounders, positive SAVD status was associated with an adverse effect on graft survival at both 1 year (HR 1.35, p < 0.001) and 10 years (HR 1.15, p < 0.001).
SAVD should be considered an independent risk factor for poor prognosis in patients undergoing kidney transplant.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.trim.2022.101734</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0966-3274 |
ispartof | Transplant immunology, 2022-12, Vol.75, p.101734-101734, Article 101734 |
issn | 0966-3274 1878-5492 |
language | eng |
recordid | cdi_proquest_miscellaneous_2732538286 |
source | Elsevier ScienceDirect Journals |
subjects | Atherosclerosis Graft survival Kidney transplantation Prognostication Rejection |
title | Symptomatic atherosclerotic vascular disease and graft survival in primary kidney transplant recipients – Observational analysis of the united network of organ sharing database |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A13%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Symptomatic%20atherosclerotic%20vascular%20disease%20and%20graft%20survival%20in%20primary%20kidney%20transplant%20recipients%20%E2%80%93%20Observational%20analysis%20of%20the%20united%20network%20of%20organ%20sharing%20database&rft.jtitle=Transplant%20immunology&rft.au=Otunla,%20Afolarin%20A.&rft.date=2022-12&rft.volume=75&rft.spage=101734&rft.epage=101734&rft.pages=101734-101734&rft.artnum=101734&rft.issn=0966-3274&rft.eissn=1878-5492&rft_id=info:doi/10.1016/j.trim.2022.101734&rft_dat=%3Cproquest_cross%3E2732538286%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2732538286&rft_id=info:pmid/&rft_els_id=S0966327422002088&rfr_iscdi=true |